149 related articles for article (PubMed ID: 12518328)
1. Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice.
Marinese D; Patel R; Walden PD
Prostate; 2003 Feb; 54(3):230-7. PubMed ID: 12518328
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
[TBL] [Abstract][Full Text] [Related]
3. Induction of atypical prostatic hyperplasia in rats by sympathomimetic stimulation.
Golomb E; Kruglikova A; Dvir D; Parnes N; Abramovici A
Prostate; 1998 Feb; 34(3):214-21. PubMed ID: 9492850
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
Tahmatzopoulos A; Kyprianou N
Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
[TBL] [Abstract][Full Text] [Related]
5. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
6. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
[TBL] [Abstract][Full Text] [Related]
7. Alpha1L-adrenoceptors mediate contractions of the isolated mouse prostate.
Gray KT; Ventura S
Eur J Pharmacol; 2006 Jul; 540(1-3):155-61. PubMed ID: 16716294
[TBL] [Abstract][Full Text] [Related]
8. Stromal fibrosis reaction in rat prostates induced by alpha 1 adrenergic stimulation.
Rosenzweig-Bublil N; Abramovici A
J Androl; 2006; 27(2):276-84. PubMed ID: 16304211
[TBL] [Abstract][Full Text] [Related]
9. Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.
Wong WC; Chiu G; Wetzel JM; Marzabadi MR; Nagarathnam D; Wang D; Fang J; Miao SW; Hong X; Forray C; Vaysse PJ; Branchek TA; Gluchowski C; Tang R; Lepor H
J Med Chem; 1998 Jul; 41(14):2643-50. PubMed ID: 9651170
[TBL] [Abstract][Full Text] [Related]
10. Biologic feature of prostatic hyperplasia developed in spontaneously hypertensive rats.
Zhang X; Na Y; Guo Y
Urology; 2004 May; 63(5):983-8. PubMed ID: 15135004
[TBL] [Abstract][Full Text] [Related]
11. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat.
Tang LM; Cheng JT; Tong YC
Neurosci Lett; 2004 Sep; 367(2):224-7. PubMed ID: 15331158
[TBL] [Abstract][Full Text] [Related]
13. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
[TBL] [Abstract][Full Text] [Related]
14. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats.
Golomb E; Rosenzweig N; Eilam R; Abramovici A
J Androl; 2000; 21(1):58-64. PubMed ID: 10670520
[TBL] [Abstract][Full Text] [Related]
16. Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum.
Reilly CM; Stopper VS; Mills TM
J Androl; 1997; 18(1):26-31. PubMed ID: 9089065
[TBL] [Abstract][Full Text] [Related]
17. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
Benning CM; Kyprianou N
Cancer Res; 2002 Jan; 62(2):597-602. PubMed ID: 11809715
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist.
Boesch ST; Corvin S; Zhang J; Rogatsch H; Bartsch G; Klocker H
Prostate; 1999 Jun; 39(4):226-33. PubMed ID: 10344211
[TBL] [Abstract][Full Text] [Related]
19. Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line.
Thebault S; Zholos A; Enfissi A; Slomianny C; Dewailly E; Roudbaraki M; Parys J; Prevarskaya N
J Cell Physiol; 2005 Jul; 204(1):320-8. PubMed ID: 15672411
[TBL] [Abstract][Full Text] [Related]
20. Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.
Kojima Y; Sasaki S; Shinoura H; Hayase M; Kubota Y; Hayashi Y; Tsujimoto G; Kohri K
Prostate; 2007 Sep; 67(12):1285-92. PubMed ID: 17626248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
